Conversely, BCL-XL inhibition strongly impaired adenoma outgrowth and A-1155463 treated TAs showed elevated expression of cleaved caspase-3 (Fig. 3b, c and Supplementary Fig. 3b, c). Here, BCL2L1 is linked to adenoma.